Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 146,000 | 168,000 | 208,000 | 287,000 | 188,000 |
| Receivables | 1,608,000 | 1,580,000 | 1,587,000 | 1,580,000 | 1,548,000 |
| Inventories | 1,166,000 | 1,134,000 | 1,087,000 | 1,113,000 | 1,078,000 |
| Income taxes - deferred | N/A | N/A | N/A | 50,000 | N/A |
| Other current assets | 922,000 | 1,046,000 | 1,001,000 | 1,050,000 | 942,000 |
| TOTAL | $4,003,000 | $3,971,000 | $3,929,000 | $4,080,000 | $3,822,000 |
| Non-Current Assets | |||||
| PPE Net | 1,782,000 | 1,730,000 | 1,715,000 | 1,700,000 | 1,697,000 |
| Intangibles | 14,283,000 | 13,885,000 | 13,176,000 | 12,697,000 | 12,835,000 |
| Other Non-Current Assets | 932,000 | 794,000 | 796,000 | 725,000 | 688,000 |
| TOTAL | $16,997,000 | $16,409,000 | $15,687,000 | $15,122,000 | $15,220,000 |
| Total Assets | $20,999,000 | $20,379,000 | $19,615,000 | $19,202,000 | $19,042,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,820,000 | 1,685,000 | 962,000 | 1,801,000 |
| Accounts payable and accrued liabilities | 349,000 | 453,000 | 403,000 | 404,000 | 530,000 |
| Accrued Expenses | 2,246,000 | 2,469,000 | 2,266,000 | 2,447,000 | 2,456,000 |
| Other current liabilities | 412,000 | 340,000 | 399,000 | 1,174,000 | 867,000 |
| TOTAL | $5,260,000 | $5,082,000 | $4,753,000 | $4,988,000 | $5,654,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,803,000 | 4,806,000 | 4,808,000 | 4,803,000 | 3,815,000 |
| Other Non-Current Liabilities | 1,882,000 | 1,774,000 | 1,945,000 | 2,254,000 | 2,370,000 |
| TOTAL | $7,013,000 | $7,008,000 | $7,117,000 | $7,185,000 | $6,376,000 |
| Total Liabilities | $12,273,000 | $12,090,000 | $11,871,000 | $12,172,000 | $12,030,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,385,962 | 1,383,801 | 1,382,925 | 1,379,811 | 1,374,911 |
| Common Shares | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Retained earnings | -6,953,000 | -7,339,000 | -7,770,000 | -8,326,000 | -8,390,000 |
| Other shareholders' equity | 34,000 | 25,000 | -16,000 | -127,000 | -58,000 |
| TOTAL | $8,726,000 | $8,289,000 | $7,744,000 | $7,030,000 | $7,012,000 |
| Total Liabilities And Equity | $20,999,000 | $20,379,000 | $19,615,000 | $19,202,000 | $19,042,000 |